Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

News Details

Dohmen leaders named to BioForward Board of Directors, poised to spark more innovation in Wisconsin

Showcasing Dohmen’s commitment to growing the life sciences sector in Wisconsin, today BioForward, the state’s growing biohealth industry association, named Dohmen leaders to its Board of Directors. Eric Floyd, Ph.D., MBA, Chief Science Officer for Dohmen Life Science Services was appointed for the 2017-19 term. Floyd joins Joe Hammer, Dohmen’s Chief Development Officer who also serves as Chairman of the BioForward Board.

In a recent press release Hammer shared, “Each BioForward Director represents best-in-class products and services from their respective fields - everything from medical device and research to biopharma and digital health right here in Wisconsin. Now we are converging to not only develop integrated health solutions, but also to accelerate our sector’s growth and attract tomorrow’s innovators to Wisconsin’s front door.”

Eric Floyd - Media Center Image“I’ve worked in this industry for over four decades, seeing innovation happen in everything from small research discoveries to large-scale collaborative efforts. As a BioForward Director, I look forward to working with Wisconsin’s very best innovators to change the state of healthcare for our industries and most importantly, for the clients and patients we serve,” added Floyd.

Dohmen’s CEO Cynthia LaConte also served on the board for three years. BioForward was founded in 1987, originally as a partnership among leaders in Wisconsin’s emerging biotechnology industry. Today the organization is a powerful advocate for Wisconsin’s life science, healthcare and research leaders and start-ups. Visit BioForward for more information.